ROPIVACAINE B BRAUN 7.5 mg/ml, solution for injection in an ampoule 20 ampoules of 10 ml
Active ingredients: (S)-N-(2,6-dimethylphenyl)-1-ethylpiperidine-2-carboxamide
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection20 ampoules of 10 mlpéridurale;périneurale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ROPIVACAINE B BRAUN 7,5 mg/ml, solution injectable en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- péridurale;périneurale
- Presentation description
- 20 ampoule(s) polyéthylène de 10 ml
- Marketing authorisation holder
- B BRAUN MELSUNGEN
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 21 Dec 2016
- Prescription and dispensing conditions
- Prescription only, hospital use
- List II: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68674482CIP75795814CIP133400957958145Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE ROPIVACAÏNE MONOHYDRATÉsolution | 7,5 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.